CME
What Factors Impact Use of ADCs in Special Patient Populations with Metastatic TNBC?
Host: Sara A. Hurvitz, MD, FACP This program provides education to help clinicians confidently diagnose and make informed clinical decisions with their patients, ultimately enhancing clinical outcomes in the evolving treatment landscape of ADCs